These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 9701463)
1. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients. Wada H; Sakuragawa N; Shiku H Semin Thromb Hemost; 1998; 24(3):293-7. PubMed ID: 9701463 [TBL] [Abstract][Full Text] [Related]
2. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group. Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656 [TBL] [Abstract][Full Text] [Related]
3. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group. Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Shiku H Thromb Haemost; 1995 Sep; 74(3):848-52. PubMed ID: 8571309 [TBL] [Abstract][Full Text] [Related]
4. Hemostatic molecular markers before the onset of disseminated intravascular coagulation. Wada H; Sakuragawa N; Mori Y; Takagi M; Nakasaki T; Shimura M; Hiyoyama K; Nisikawa M; Gabazza EC; Deguchi K; Kazama M; Shiku H Am J Hematol; 1999 Apr; 60(4):273-8. PubMed ID: 10203100 [TBL] [Abstract][Full Text] [Related]
5. Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation. Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Deguchi H; Mori Y; Kaneko T; Deguchi K; Fujii J; Shiku H Am J Hematol; 1996 Apr; 51(4):255-60. PubMed ID: 8602623 [TBL] [Abstract][Full Text] [Related]
6. [Clinical application of laboratory diagnosis: leukemia and DIC]. Deguchi K; Zhao LJ; Shirakawa S Rinsho Byori; 1991 Jul; 39(7):736-42. PubMed ID: 1833571 [TBL] [Abstract][Full Text] [Related]
7. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260 [TBL] [Abstract][Full Text] [Related]
8. [Plasma fibrin monitor level in DIC patients with a hematopoietic malignancy]. Hiyoyama K; Wada H; Shimura M; Deguchi H; Nagaya S; Wakita Y; Deguchi K; Shiku H Rinsho Byori; 1996 Jan; 44(1):57-60. PubMed ID: 8691641 [TBL] [Abstract][Full Text] [Related]
9. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)]. Koga S Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605 [TBL] [Abstract][Full Text] [Related]
10. [Hemostatic abnormalities in DIC]. Wada H Rinsho Byori; 2002 Aug; 50(8):768-72. PubMed ID: 12373812 [TBL] [Abstract][Full Text] [Related]
11. [Hemostatic changes before and after the onset of disseminated intravascular coagulation]. Wada H; Tanigawa M; Takagi M; Suzuki H; Mori Y; Ohta T; Kobayashi T; Kita K; Tanaka I; Yamaguchi T Rinsho Ketsueki; 1989 Oct; 30(10):1755-62. PubMed ID: 2593241 [TBL] [Abstract][Full Text] [Related]
12. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation]. Fukuda C; Iijima K; Nakamura K Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061 [TBL] [Abstract][Full Text] [Related]
13. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation. Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation. Ohkura N; Soe G; Kohno I; Kumeda K; Wada H; Kamikubo Y; Shiku H; Kato H Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212 [TBL] [Abstract][Full Text] [Related]
17. Good or poor responses of hemostatic molecular markers in patients with hematopoietic disorders after treatment of disseminated intravascular coagulation. Watanabe R; Wada H; Yamamuro M; Inoue A; Watanabe M; Kumeda K; Sakakura M; Okugawa Y; Nakasaki T; Deguchi H; Gabazza EC; Mori Y; Nishikawa M; Nobori T; Shiku H Clin Appl Thromb Hemost; 2003 Jan; 9(1):71-7. PubMed ID: 12643327 [TBL] [Abstract][Full Text] [Related]
18. Hemostatic study before onset of disseminated intravascular coagulation. Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi A; Mori Y; Deguchi K Am J Hematol; 1993 Jul; 43(3):190-4. PubMed ID: 8352234 [TBL] [Abstract][Full Text] [Related]
19. Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit. Okabayashi K; Wada H; Ohta S; Shiku H; Nobori T; Maruyama K Am J Hematol; 2004 Jul; 76(3):225-9. PubMed ID: 15224356 [TBL] [Abstract][Full Text] [Related]